Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Dec 10;16(1):18-19.
doi: 10.1021/acsmedchemlett.4c00581. eCollection 2025 Jan 9.

Novel 3-Pyrrolidineindole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis and Mental Illnesses Such as Depression and Post-Traumatic Stress Disorder

Ram W Sabnis  1
Affiliations
Editorial

Novel 3-Pyrrolidineindole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis and Mental Illnesses Such as Depression and Post-Traumatic Stress Disorder

Ram W Sabnis. ACS Med Chem Lett. .

Abstract

Provided herein are novel 3-pyrrolidineindole derivatives as serotonergic psychedelic agents, pharmaceutical compositions, use of such compounds in treating psychosis and mental illnesses such as depression and post-traumatic stress disorder, and processes for preparing such compounds.

PubMed Disclaimer

Conflict of interest statement

The author declares no competing financial interest.

References

    1. Duan W.; Cao D.; Wang S.; Cheng J. Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants. Chem. Rev. 2024, 124, 124–163. 10.1021/acs.chemrev.3c00375. - DOI - PubMed
    1. Miranda L. Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants. Brain Res. 2025, 1846, 149226.10.1016/j.brainres.2024.149226. - DOI - PubMed
    1. Glennon R. A.; Dukat M. 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents – A Review. ACS Pharmacol. Transl. Sci. 2024, 7, 1722–1745. 10.1021/acsptsci.4c00157. - DOI - PMC - PubMed
    1. Korkmaz N. D.; Cikrikcili U.; Akan M.; Yucesan E. Psychedelic therapy in depression and substance use disorders. Eur. J. Neurosci. 2024, 60, 4063–4077. 10.1111/ejn.16421. - DOI - PubMed
    1. Bremshey S.; Groß J.; Renken K.; Masseck O. A. The role of serotonin in depression—A historical roundup and future directions. J. Neurochem. 2024, 168, 1751–1779. 10.1111/jnc.16097. - DOI - PubMed

Publication types

LinkOut - more resources